Table 3.
Therapeutic groups and affected organs related to ADRs
| n = 19 ADRs | Total | |
|---|---|---|
| Pharmacological groups (ATC code-First level) | ||
| -Antiinfectives (J) | 12** | |
| -Nervous System (N) | 3 | |
| -Blood and blood forming organs (B) | 1 | |
| -Sensory organs (V) | 1 | |
| -Alimentary tract and metabolism (A) | 2 | |
| Distribution by affected organs and systems | ||
| -Nervous system | Anxiety (2), headache(2), drowsiness (1) | 5 |
| -Skin and annexes | Rash (9), intense pruritus (2) | 11 |
| -Blood and blood forming organs | Hemolysis (1) | 1 |
| -Cardiovascular system | ||
| -Immunological system | Hypertension (2), hypotension (1) | 3 |
| -Gastrointestinal tract | Fever (2), anaphylaxis (1) | 3 |
| -Sensory organs | Diahrrea (1) | 1 |
| -Muscle-skeletal system | Diplopia (1) | 1 |
| -General effects | Paresthesias (1) | 1 |
| General discomfort (1) | 1 | |
Therapeutic groups and affected organs related to ADRs ADRs were classified according to the ATC Code-First Level and their distribution by affected organs and systems
**The relationship between the amount of AB and ADR was significant (s < 0.05; Chi-square) and also the presence of ADR and third day of AB (P < 0.05; Chi-square)
ADRs Adverse Drug Reactions